欧州に多いCD83近傍のバリアントとアジアに多いIL17RB近傍バリアントが、トファシチニブにおける帯状疱疹リスクに及ぼす影響: GWAS研究のメタ解析

Arthritis Rheumatol. 2021;73(7):1155–66

Genetic analysis of tofacitinib-treated subjects with RA or PsO identified multiple loci associated with increased herpes zoster (HZ) risk.It is well known that HZ risk is elevated in subjects with RA compared with the general population, and that treatment with JAK inhibitors may result in increased risks compared with TNFi and other bDMARD treatments. To this end, Bing, et al. used genome-wide association studies to identify genetic factors associated with an increased risk/faster onset of HZ in subjects with RA or PsO receiving tofacitinib treatment.

Keywords:


Publication thumbnail: 欧州に多いCD83近傍のバリアントとアジアに多いIL17RB近傍バリアントが、トファシチニブにおける帯状疱疹リスクに及ぼす影響: GWAS研究のメタ解析
LinkedIn